This research shows that genetic risk scores alone are insufficient for predicting chronic disease. By incorporating social and environmental factors using machine learning, disease prediction improves substantially, especially for disadvantaged populations. Integrating genetic and social risk is essential for equitable, effective personalized medicine.

This research develops a protein-based detection technology capable of identifying subtle molecular changes months before disease symptoms appear. By adapting nanopore sequencing with a protein “detangler,” it enables early warning for conditions like leukemia, shifting medicine from reactive treatment to proactive disease prevention.